Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Sectors

Vedanta sparks life into open innovation

The Spark initiative in partnership with incubator Forge had 1,350 registrations with 23 accepted.


Nov 4, 2021

Cross River starts Digital Ventures unit

Hillel Olivestone, Cross River’s head of corporate development, will run unit.

Nov 4, 2021

Clade Therapeutics clasps $87m

Bristol Myers Squibb was among the participants in cellular therapy developer Clade Therapeutics' series A round, with the proceeds to go to platform development.

Nov 4, 2021

Corporates enter Parthenon in $65m series A

Cancer drug developer Parthenon Therapeutics secured the funding in a series A round co-led by Pfizer Ventures and Taiho Ventures.

Nov 4, 2021

GCV Symposium 2021: Impact keynote – A climate change innovator

Hitachi’s chief environmental officer Alistair Dormer gave a keynote on the firm’s commitment to sustainability through innovation.

Nov 4, 2021

Daily Deal Round Up: November 3, 2021

Cox Enterprises invested in digital media company Axios at a $430m valuation while Bristol Myers Squibb helped enzyme drug developer Nitrase Therapeutics boost its series A round to $45m.

Nov 3, 2021

GCV Symposium 2021: Neom’s energy vision

Jens Madrian introduces Neom Energy, which is set to start investing in technology companies from 2023.

Nov 3, 2021

GCV Symposium 2021: TDK Ventures two years on

GCV’s James Mawson interviewed TDK Ventures‘ Nicolas Sauvage about his unit’s track record since it was founded in 2019.

Nov 3, 2021

Coca-Cola fortifies itself with Bodyarmor

Coca-Cola paid $5.6bn for the 85% of the sports drink brand it did not already own, having invested an undisclosed amount three years ago.

Nov 3, 2021

Nubank files for dual listing

The Tencent and Berkshire Hathaway-backed digital bank is seeking to grow its valuation from $30bn in June to over $50m in flotations in the US and Brazil.

Nov 3, 2021
© 2025 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here